Switch theme
Sign up to access all valuation multiples
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
2002
188
LTM Revenue $61.9M
LTM EBITDA -$46.1M
$190M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Codexis has a last 12-month revenue (LTM) of $61.9M and a last 12-month EBITDA of -$46.1M.
In the most recent fiscal year, Codexis achieved revenue of $59.3M and an EBITDA of -$53.4M.
Codexis expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Codexis valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $61.9M | XXX | $59.3M | XXX | XXX | XXX |
| Gross Profit | $43.9M | XXX | $43.1M | XXX | XXX | XXX |
| Gross Margin | 71% | XXX | 73% | XXX | XXX | XXX |
| EBITDA | -$46.1M | XXX | -$53.4M | XXX | XXX | XXX |
| EBITDA Margin | -74% | XXX | -90% | XXX | XXX | XXX |
| EBIT | -$56.0M | XXX | -$58.4M | XXX | XXX | XXX |
| EBIT Margin | -90% | XXX | -98% | XXX | XXX | XXX |
| Net Profit | -$62.4M | XXX | -$65.3M | XXX | XXX | XXX |
| Net Margin | -101% | XXX | -110% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $9.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Codexis's stock price is $2.
Codexis has current market cap of $191M, and EV of $190M.
See Codexis trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $190M | $191M | XXX | XXX | XXX | XXX | $-0.81 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Codexis has market cap of $191M and EV of $190M.
Codexis's trades at 3.2x EV/Revenue multiple, and -3.6x EV/EBITDA.
Equity research analysts estimate Codexis's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Codexis has a P/E ratio of -3.1x.
See valuation multiples for Codexis and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $191M | XXX | $191M | XXX | XXX | XXX |
| EV (current) | $190M | XXX | $190M | XXX | XXX | XXX |
| EV/Revenue | 3.1x | XXX | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | -4.1x | XXX | -3.6x | XXX | XXX | XXX |
| EV/EBIT | -3.4x | XXX | -3.3x | XXX | XXX | XXX |
| EV/Gross Profit | 4.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | -3.1x | XXX | -2.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -3.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCodexis's last 12 month revenue growth is 16%
Codexis's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.5M for the same period.
Codexis's rule of 40 is -48% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Codexis's rule of X is -35% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Codexis and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Margin | -74% | XXX | -90% | XXX | XXX | XXX |
| EBITDA Growth | -5% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -48% | XXX | -74% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -35% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 78% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 171% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Corbion | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| Industries Qatar | XXX | XXX | XXX | XXX | XXX | XXX |
| K+S | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Codexis acquired XXX companies to date.
Last acquisition by Codexis was XXXXXXXX, XXXXX XXXXX XXXXXX . Codexis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Codexis founded? | Codexis was founded in 2002. |
| Where is Codexis headquartered? | Codexis is headquartered in United States of America. |
| How many employees does Codexis have? | As of today, Codexis has 188 employees. |
| Who is the CEO of Codexis? | Codexis's CEO is Dr. Stephen Dilly, M.B.B.S.,PhD. |
| Is Codexis publicy listed? | Yes, Codexis is a public company listed on NAS. |
| What is the stock symbol of Codexis? | Codexis trades under CDXS ticker. |
| When did Codexis go public? | Codexis went public in 2010. |
| Who are competitors of Codexis? | Similar companies to Codexis include e.g. Fertiglobe, Corbion, Gujarat State Fertilizers & Chemicals, Industries Qatar. |
| What is the current market cap of Codexis? | Codexis's current market cap is $191M |
| What is the current revenue of Codexis? | Codexis's last 12 months revenue is $61.9M. |
| What is the current revenue growth of Codexis? | Codexis revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of Codexis? | Current revenue multiple of Codexis is 3.1x. |
| Is Codexis profitable? | Yes, Codexis is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Codexis? | Codexis's last 12 months EBITDA is -$46.1M. |
| What is Codexis's EBITDA margin? | Codexis's last 12 months EBITDA margin is -74%. |
| What is the current EV/EBITDA multiple of Codexis? | Current EBITDA multiple of Codexis is -4.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
